Woman contracts ovarian cancer after using Johnson & Johnson's products

ruby orimba

August 22, 2017 11:41 AM

The court ordered the company to pay her a whooping 417million dollars.

___7183683___https:______static.pulse.com.gh___webservice___escenic___binary___7183683___2017___8___22___10___ovarian+a

With thousands of lawsuits filed against their products, drugmaker Johnson & Johnson has been ordered by a California court to pay $417million to a 63-year-old woman who claims to have fallen terminally ill after using the companys product.

The multibillion-dollar company was accused of not informing its consumers of the risk of cancer from talc in its products.

Eva Echeverria, the plaintiff, claimed to have contracted terminal ovarian cancer after decades of using the company's talc-based products for feminine hygiene.

So far the courts of law have also awarded damages against Johnson & Johnson totaling more than $307 million similar talc cases.

However, Johnson & Johnson are set to appeal.

In a media statement the company spokesperson, Carol Goodrich, announced the company's intention to appeal the matter citing the editorial board of the National Cancer Insititute's Physician's Data Query which declares that the weight of the evidence does not support the existence of a link between ovarian cancer and exposure to the genital region to talc.

Talc is a hydrous magnesium silicate mineral that can be crushed into a white powder which has the ability to absorb moisture, absorb oils, absorb odor, serve as a lubricant, and produce an astringent effect on human skin.

These properties make talcum powder an important ingredient in many baby powders, foot powders, first aid powders, and a variety of cosmetics.